VAN Anh Nguyen - JoVE Visualize

Showing results (111-120 of 118) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 118 results.

The Lancet. Child & Adolescent Health|April 13, 2026

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trialPieter A De Cock, Roos Colman, Anne Smits, et al.

Children (Basel, Switzerland)|May 27, 2026

Clinical Phenotypes and Genetic Findings in Very-Early-Onset Inflammatory Bowel Disease: A Vietnamese Pediatric Cohort StudyManh Cuong Nguyen, Thi Viet Ha Nguyen, Loi Nguyen, et al.

Frontiers in Oncology|December 29, 2022

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patientsHuu Thinh Nguyen, Trieu Vu Nguyen, Van-Anh Nguyen Hoang, et al.

Journal for Immunotherapy of Cancer|May 14, 2021

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort studyNikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.

Science Translational Medicine|March 16, 2022

Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responsesKunle Odunsi, Feng Qian, Amit A Lugade, et al.

EMBO Molecular Medicine|November 7, 2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.

Frontiers in Immunology|July 28, 2017

Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined ImmunodeficiencyAnderson Dik Wai Luk, Pamela P Lee, Huawei Mao, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022

Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandKatharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.

Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 118 results.

The Lancet. Child & Adolescent Health|April 13, 2026

Bedside model-informed precision dosing of vancomycin in severely ill neonates and children in Belgium (the BENEFICIAL trial): a multicentre, randomised controlled trialPieter A De Cock, Roos Colman, Anne Smits, et al.

Children (Basel, Switzerland)|May 27, 2026

Clinical Phenotypes and Genetic Findings in Very-Early-Onset Inflammatory Bowel Disease: A Vietnamese Pediatric Cohort StudyManh Cuong Nguyen, Thi Viet Ha Nguyen, Loi Nguyen, et al.

Frontiers in Oncology|December 29, 2022

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patientsHuu Thinh Nguyen, Trieu Vu Nguyen, Van-Anh Nguyen Hoang, et al.

Journal for Immunotherapy of Cancer|May 14, 2021

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort studyNikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.

Science Translational Medicine|March 16, 2022

Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responsesKunle Odunsi, Feng Qian, Amit A Lugade, et al.

EMBO Molecular Medicine|November 7, 2022

Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.

Frontiers in Immunology|July 28, 2017

Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined ImmunodeficiencyAnderson Dik Wai Luk, Pamela P Lee, Huawei Mao, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|November 26, 2022

Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and SwitzerlandKatharina Schumann, Cornelia Mauch, Kai-Christian Klespe, et al.

Pageof 12